Applied Molecular Transport (Applied Molecular Transport) Interest Received

View and export this data going back to 2020. Start your Free Trial

What is Applied Molecular Transport Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

Applied Molecular Transport (Applied Molecular Transport) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Applied Molecular Transport Inc (NAS:AMTI) » Definitions » Interest Received

Comparable Companies

Traded in Other Exchanges

N/A

Address

450 East Jamie Court, South San Francisco, CA, USA, 94080

Website

https://www.appliedmt.com

Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.

Executives

Shawn Cross	officer: Chief Financial Officer	1825 K STREET SUITE 510, WASHINGTON DC 20006
Mahmood Tahir Ph.d.	director, officer: Chief Executive Officer	1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Brandon Hants	officer: VP, Finance & Bus. Ops.	1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Douglas A. Rich	officer: Chief Technical Officer	C/O KYTHERA BIOPHARMACEUTICALS, INC., 30930 RUSSELL RANCH ROAD, 3RD FLOOR, WESTLAKE VILLAGE CA 91362
Bittoo Kanwar	officer: Chief Medical Officer	1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Mrsny Randall Ph.d.	director, officer: Chief Scientific Officer	1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Aaron Vandevender	director	1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
David Lamond	director	C/O CORTEXYME, INC., 269 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080
Epiq Capital Group, Llc	other: Managing member of 10% owner	ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111
Chad Boeding	other: CEO of Managing Member	ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111
Charlene A. Banard	director	C/O APPLIED MOLECULAR TRANSPORT INC., 450 EAST JAMIE COURT, SOUTH SAN FRANCISCO CA 94080
John W Smither	director	C/O KYTHERA BIOPHARMACEUTICALS, INC., 27200 WEST AGOURA ROAD, SUITE 200, CALABASAS CA 91301
Epq Llc Amt Ps	other: Owner	9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521
Epq Llc, Amtc Ps	other: Owner	9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521
Epq Llc, Amtb Ps	10 percent owner	9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521